Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.55 |
| ▸ | AGXT | P21549 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.51 |
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.49 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.49 |
| ▸ | LPO | P22079 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8784075 | 0.93 | TAAR1 (0.49) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL28141102 | 0.89 | CMA1 (0.45) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL8992947 | 0.88 | LTA4H (0.49) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL10545623 | 0.88 | SMN1; SMN2 (0.56) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL8992807 | 0.84 | CNR2 (0.46) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL8993396 | 0.84 | CNR2 (0.48) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL27295522 | 0.82 | MAOB (0.47) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL1233549 | 0.81 | MEN1 (0.66) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL2294721 | 0.81 | TP53 (0.50) | CHRM2CHRM1CHRM3ENPP2 | |
| SCHEMBL8596617 | 0.81 | SMN1; SMN2 (0.56) | MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720073-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | Kura Oncology, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| WO-2024245364-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | KURA ONCOLOGY, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-114248574-A | Application of thermo-reversible piezochromic dye in inkless printing technology | 天津理工大学 | 2022-03-29 | — | — | CN | claimed |
| US-7923110-B2 | Metal nanoparticle having a self-assembled monolayer on its surface, and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-04-12 | — | — | US | claimed |
| US-20080020317-A1 | Novel metal nanoparticle and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-24 | — | — | US | claimed |
| US-20080003363-A1 | Novel metal nanoparticle and method for formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-03 | — | — | US | claimed |
| US-5220019-A | Process for the preparation of diethyl 2-]2-cyano-5-(dimethylamino)-2-(3-methoxyphenyl)-1,1-dimethylpentyl]propandioate | G. D. SEARLE & CO. (US) | 1993-06-15 | — | — | US | claimed |
| EP-0448972-A2 | Process for preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines | G.D. Searle & Co. (US) | 1991-10-02 | — | — | EP | claimed |
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | KURA ONCOLOGY INC (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4720073-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | Kura Oncology, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-12466835-B1 | Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same | KURA ONCOLOGY, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| WO-2025105873-A1 | EASILY INSERTABLE AND REMOVABLE MENSTRUAL CUP FOR PREVENTING COLORING | 주식회사 올담 | 2025-05-22 | — | — | WO | disclosed |
| EP-4532484-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2025-04-09 | — | — | EP | disclosed |
| US-4178460-A | INTERMEDIATES FOR INSECTICIDES | AMERICAN CYANAMID CO. (US) | 1979-12-11 | — | — | US | disclosed |
| US-4072716-A | Bicycloalkane derivatives | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-02-07 | — | — | US | disclosed |
| US-4051188-A | NOVEL BICYCLOALKANE DERIVATIVES AND THE PRODUCTION THEREOF | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4008253-A | Bicycloalkanes | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-02-15 | — | — | US | disclosed |
| US-3944571-A | ANTIARTHRITIC | SMITHKLINE CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
| US-3817985-A | NEW N-CYCLOPROPYLMETHYL AZETIDINE COMPOUNDS AND PROCESS FOR THEIR PRODUCTION | PARKE DAVIS & CO | 1974-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | FDPS, PCTP, MTTP | TAAR1 4095/4885IDO1 4800/4885AGXT 1376/4885 |
| US-12466835-B1 | Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same | FNTA, SF3B1, SF3A1 | TAAR1 4883/4885IDO1 4824/4885AGXT 2459/4885 |
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | ROCK1, ROCK2, RHOA | TAAR1 4477/4885IDO1 2546/4885AGXT 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.